Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 17956625)

1.

Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy.

Carta MG, Hardoy MC, Garofalo A, Pisano E, Nonnoi V, Intilla G, Serra G, Balestrieri C, Chessa L, Cauli C, Lai ME, Farci P.

Clin Pract Epidemiol Ment Health. 2007 Oct 23;3:22.

2.

Association of chronic hepatitis C with recurrent brief depression.

Carta MG, Angst J, Moro MF, Mura G, Hardoy MC, Balestrieri C, Chessa L, Serra G, Lai ME, Farci P.

J Affect Disord. 2012 Dec 10;141(2-3):361-6. doi: 10.1016/j.jad.2012.03.020. Epub 2012 May 18.

PMID:
22609196
3.

[Hepatitis C, interferon a and depression: main physiopathologic hypothesis].

Vignau J, Karila L, Costisella O, Canva V.

Encephale. 2005 May-Jun;31(3):349-57. Review. French.

PMID:
16142050
4.
5.

Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.

Reddy A, May E, Ehrinpreis M, Mutchnick M.

World J Gastroenterol. 2013 Dec 28;19(48):9328-33. doi: 10.3748/wjg.v19.i48.9328.

6.

Enhancing the response to interferon-alpha.

Begemann F, Jablonowski H.

J Clin Virol. 1999 Jun;13(1-2):1-7.

PMID:
10405886
7.

Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.

Mavrogiannaki A, Karamanos B, Manesis EK, Papatheodoridis GV, Koskinas J, Archimandritis AJ.

J Viral Hepat. 2009 Jun;16(6):430-6. doi: 10.1111/j.1365-2893.2009.01077.x. Epub 2009 Feb 6.

PMID:
19200136
8.

[Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].

Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M.

Encephale. 2009 Oct;35(5):477-83. doi: 10.1016/j.encep.2007.09.007. Epub 2008 Jun 12. French.

PMID:
19853722
9.

Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis.

Zografos TA, Rigopoulou EI, Liaskos C, Togousidis E, Zachou K, Gatselis N, Germenis A, Dalekos GN.

J Hepatol. 2006 May;44(5):848-55. Epub 2006 Feb 17.

PMID:
16530290
10.

[Haematologic adverse effects of treatment of chronic viral hepatitis B and C].

Porubcin S, Schréter I, Kristian P, Pellová A.

Klin Mikrobiol Infekc Lek. 2008 Apr;14(2):74-8. Slovak.

PMID:
18756437
11.

Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.

Zografos TA, Liaskos C, Rigopoulou EI, Togousidis E, Makaritsis K, Germenis A, Dalekos GN.

Am J Gastroenterol. 2008 Mar;103(3):605-14. doi: 10.1111/j.1572-0241.2007.01729.x. Epub 2008 Jan 8.

PMID:
18190648
12.

Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.

Laguno M, Blanch J, Murillas J, Blanco JL, León A, Lonca M, Larrousse M, Biglia A, Martinez E, García F, Miró JM, de Pablo J, Gatell JM, Mallolas J.

Antivir Ther. 2004 Dec;9(6):905-9.

PMID:
15651749
13.

[Alpha-interferon and mental disorders].

Debien C, De Chouly De Lenclave MB, Foutrein P, Bailly D.

Encephale. 2001 Jul-Aug;27(4):308-17. Review. French.

PMID:
11686052
14.

Effects of metabolic syndrome on fibrosis in chronic viral hepatitis.

Yoon H, Lee JG, Yoo JH, Son MS, Kim DY, Hwang SG, Rim KS.

Gut Liver. 2013 Jul;7(4):469-74. doi: 10.5009/gnl.2013.7.4.469. Epub 2013 Jun 20.

15.

Overview and clinical presentation of generalized anxiety disorder.

Rickels K, Rynn M.

Psychiatr Clin North Am. 2001 Mar;24(1):1-17. Review.

PMID:
11225502
16.

Modulation of tumor necrosis factor receptors 1 and 2 in chronic hepatitis B and C: the differences and implications in pathogenesis.

Tai DI, Tsai SL, Chen TC, Lo SK, Chang YH, Liaw YF.

J Biomed Sci. 2001 Jul-Aug;8(4):321-7.

PMID:
11455194
17.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

18.

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.

Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P.

Gastroenterology. 2008 Feb;134(2):416-23. doi: 10.1053/j.gastro.2007.11.010. Epub 2007 Nov 12.

PMID:
18164296
19.

Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.

Fujita N, Sugimoto R, Urawa N, Araki J, Mifuji R, Yamamoto M, Horiike S, Tanaka H, Iwasa M, Kobayashi Y, Adachi Y, Kaito M.

J Gastroenterol Hepatol. 2007 Nov;22(11):1886-93.

PMID:
17914965
20.

[Chronic hepatitis B and C in renal graft recipients].

Zubkin ML, Balakirev EM, Chervinko VI, Zolotarevskiĭ VB, Baranova FS, Taranov VA, Bakulin IG, Stanke AA, Evseev AA, Novozhenov VG.

Vestn Ross Akad Med Nauk. 2006;(11):49-52. Russian.

PMID:
17136855
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk